Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Wilkins JJ"'
Autor:
Wilkins, JJ1, Chan, PLS2, Chard, J3, Smith, G4, Smith, MK2, Beer, M5, Dunn, A3, Flandorfer, C5, Franklin, C6, Gomeni, R7, Harnisch, L2, Kaye, R3, Moodie, S8, Sardu, ML9, Wang, E10, Watson, E11, Wolstencroft, K12, Cheung, SYA13 Amy.Cheung@astrazeneca.com
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. May2017, Vol. 6 Issue 5, p285-292. 8p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sanghavi K; Clinical Pharmacology, Genmab US, Inc., Princeton, New Jersey, USA., Ribbing J; Pharmetheus AB, Uppsala, Sweden., Rogers JA; Metrum Research Group, Tariffville, Connecticut, USA., Ahmed MA; Quantitative Clinical Pharmacology, Takeda Pharmaceutical, Cambridge, Massachusetts, USA., Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Holford N; Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Chasseloup E; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Ahamadi M; Modeling and Simulation, Sanofi, Bridgewater, Sanofi, USA., Kowalski KG; PMetrics Consulting, Northville, Michigan, USA., Cole S; Medical and Healthcare product Regulatory Agency (MHRA), London, UK., Kerwash E; Medical and Healthcare product Regulatory Agency (MHRA), London, UK., Wade JR; Occams, Amstelveen, The Netherlands., Liu C; Applied Innovation Quantitative Solutions, BeiGene, Washington, DC, USA., Wang Y; Createrna Science and Technology, Clarksburg, Maryland, USA., Trame MN; Integrated Drug Development Northeast Regional Lead, Certara, Massachusetts, USA., Zhu H; Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Springs, Maryland, USA., Wilkins JJ; Occams, Amstelveen, The Netherlands.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 May; Vol. 13 (5), pp. 710-728. Date of Electronic Publication: 2024 Apr 02.
Autor:
Courlet P; Merck Institute for Pharmacometrics, Ares Trading S.A., (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland., Wilkins JJ; Occams Coöperatie UA, Amstelveen, the Netherlands., Oeuvray C; The Global Health Institute of Merck (an affiliate of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland., Gao W; EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts, USA., Khandelwal A; The healthcare business of Merck KGaA, Darmstadt, Germany.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Dec 14; Vol. 67 (12), pp. e0089123. Date of Electronic Publication: 2023 Nov 15.
Autor:
Kotani N; Genentech, Inc., South San Francisco, CA, USA. kotani.naoki47@chugai-pharm.co.jp.; Pharmaceutical Science Department, Chugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo, 103-8324, Japan. kotani.naoki47@chugai-pharm.co.jp., Wilkins JJ; Occams Coöperatie UA, Amstelveen, The Netherlands., Wade JR; Occams Coöperatie UA, Amstelveen, The Netherlands., Dang S; Genentech, Inc., South San Francisco, CA, USA., Sutaria DS; Genentech, Inc., South San Francisco, CA, USA., Yoshida K; Genentech, Inc., South San Francisco, CA, USA., Sundrani S; Genentech, Inc., South San Francisco, CA, USA.; Department of Bioengineering/Biomedical Computation, Stanford University, Stanford, CA, USA., Ding H; Genentech, Inc., South San Francisco, CA, USA., Garcia J; F. Hoffmann-La Roche AG, Basel, Switzerland., Hinton H; F. Hoffmann-La Roche AG, Basel, Switzerland., Sane R; Genentech, Inc., South San Francisco, CA, USA., Chanu P; Department of Clinical Pharmacology, Genentech/Roche, Lyon, France.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Dec; Vol. 90 (6), pp. 511-521. Date of Electronic Publication: 2022 Oct 28.
Autor:
Vugmeyster Y; EMD Serono Research and Development Institute, Inc., An Affiliate of Merck KGaA, 45 Middlesex Turnpike, Billerica, MA, 01821, USA. yulia.vugmeyster@emdserono.com., Grisic AM; Merck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany., Wilkins JJ; Occams, Amstelveen, The Netherlands., Loos AH; Merck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany., Hallwachs R; Merck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany., Osada M; Merck Biopharma Co., Ltd., An Affiliate of Merck KGaA, Tokyo, Japan., Venkatakrishnan K; EMD Serono Research and Development Institute, Inc., An Affiliate of Merck KGaA, 45 Middlesex Turnpike, Billerica, MA, 01821, USA., Khandelwal A; Merck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany. akash.khandelwal@merckgroup.com.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Oct; Vol. 90 (4), pp. 369-379. Date of Electronic Publication: 2022 Sep 06.
Autor:
Wilkins JJ; Occams Coöperatie, Amstelveen, The Netherlands. Electronic address: justin.wilkins@occams.com., Svensson EM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Ernest JP; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Simonsson USH; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Publikováno v:
International journal of antimicrobial agents [Int J Antimicrob Agents] 2022 Sep; Vol. 60 (3), pp. 106620. Date of Electronic Publication: 2022 Jun 17.
Autor:
Fidler M; Novartis Pharmaceuticals, Inc, Fort Worth, Texas, USA., Hooijmaijers R; Leiden experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P, Leiden, The Netherlands., Schoemaker R; Occams, Amstelveen, The Netherlands., Wilkins JJ; Occams, Amstelveen, The Netherlands., Xiong Y; Johnson and Johnson, Janssen Research & Development, Spring House, Pennsylvania, USA., Wang W; Novartis Pharmaceuticals, Inc, Fort Worth, Texas, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Apr; Vol. 10 (4), pp. 283-285.